UNIVERSITÉ DE BRETAGNE OCCIDENTALE (U.B.O.);INSERM;CENTRE HOSPITALIER RÃGIONAL ET UNIVERSITAIRE DE BREST
发明人:
YVES RENAUDINEAU,OLIVIER MIGNEN,MIGUEL BURGOS,JACQUES OLIVIER PERS,TINHINANE FALI
申请号：
PT14290232
公开号：
PT2982982T
申请日:
2014.08.06
申请国别(地区):
PT
年份:
2018
代理人:
摘要：
The invention relates to the use of the fraction of the STIM1 protein localized to the plasma membrane of the cells in a method for screening candidate molecules for treating chronic lymphatic leukaemia and/or systemic lupus erythematosus. The invention also relates to a substance interacting with the fraction of the STIM1 protein localized to the plasma membrane of the cells for use as a medicinal product in the treatment of chronic lymphatic leukaemia and/or systemic lupus erythematosus, as well as to a pharmaceutical composition comprising at least one substance according to the invention.
